What COVID vaccines for young kids could mean for the pandemic

As the US Food and Drug Administration authorizes shots for children aged 5 to 11, researchers predict what this might mean for populations.
By
  1. Max Kozlov
    View author publications

    You can also search for this author in PubMed  Google Scholar

Access through your institution
Buy or subscribe

The US Food and Drug Administration (FDA) has authorized a COVID-19 vaccine for the nation’s roughly 28 million 5- to 11-year-olds. The decision comes days after an agency advisory committee reviewed data from a clinical trial testing a low-dose version of the Pfizer-BioNTech vaccine on children in that age group — and voted nearly unanimously to recommend that the FDA grant emergency approval.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 599, 18-19 (2021)

doi: https://doi.org/10.1038/d41586-021-02947-z

Updates & Corrections

  • Update 29 October 2021: This story was updated to reflect that the US Food and Drug Administration has authorized the Pfizer-BioNTech COVID-19 vaccine for children.

References

  1. Fazel, M. et al. EClinicalMedicine 40, 101144 (2021).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing